PMID: 4054193Jan 1, 1985Paper

CNS-related side-effects with metoprolol and atenolol

European Journal of Clinical Pharmacology
J R Cove-Smith, C A Kirk

Abstract

Vivid and bizarre dreams, hallucinations, sleep disturbance and psychosis have all been described following treatment with beta-blockers. It has been suggested that these central nervous system (CNS) side-effects are related to the degree of lipophilicity of the beta-blocker. A randomized double-blind crossover study was performed to compare the incidence of CNS side-effects with atenolol and metoprolol in hypertensive patients who had reported CNS side-effects with lipophilic beta-blockers. Eleven women and six men completed the study, in which a 30-item psychiatric questionnaire was used to detect changes in psychological status and possible CNS side-effects. Discontinuation of the original lipophilic beta-blocker produced a significant improvement in quality of sleep, dreams, concentration, memory, energy, and anxiety. No significant CNS side-effects were reported with atenolol, but introduction of metoprolol caused a significant increase in the incidence of sleep disturbance (p less than 0.01) and restless nights (p less than 0.05), as well as failure to achieve satisfactory sexual intercourse (p less than 0.05). When compared with atenolol, metoprolol was associated with a significantly higher incidence of restless disturb...Continue Reading

References

May 6, 1978·British Medical Journal·R Fleminger
Nov 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·H S Fraser, A C Carr
Jun 1, 1981·British Journal of Clinical Pharmacology·G Neil-DwyerJ M Cruickshank
Mar 1, 1981·The Journal of Pharmacy and Pharmacology·P B Woods, M L Robinson
Aug 1, 1982·British Journal of Clinical Pharmacology·M S LennardJ Trevethick

Citations

Jan 1, 1985·European Journal of Clinical Pharmacology·W P Koella
Jul 1, 1990·Journal of General Internal Medicine·D M PalacS P Bagby
Jan 1, 1990·Pharmacology & Therapeutics·J McAinsh, J M Cruickshank
May 3, 2002·Ophthalmology·M R WilsonMatthew H Kim
Jun 11, 2011·Drug Discovery Today·Fabrizio GiordanettoChristian Tyrchan
Nov 8, 2006·General Hospital Psychiatry·Tongabay CumurcuIlker Etikan
Nov 29, 2015·Neurologic Clinics·Sai Krishna J Munjampalli, Debra E Davis
Jun 7, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Chien-Chia SuI-Jong Wang
Feb 18, 2012·Journal of Medical Case Reports·Jonathan A Goldner
Feb 11, 1999·The Annals of Pharmacotherapy·D F Thompson, D R Pierce
Jul 31, 2020·Military Medicine·Cody Armstrong, Michelle R Kapolowicz
Jul 21, 2012·Drug Metabolism and Pharmacokinetics·Chia-Hsien ChangLi-Jen Lin
Apr 21, 2001·Cardiovascular Drug Reviews·T NagatomoM Ishiguro
Sep 1, 1986·Medical Toxicology·R V Lewis, D G McDevitt
Mar 7, 2021·International Journal of Molecular Sciences·Ronni BaranMarkus Wehland

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.